Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ennio Lubrano, Michele Maria Luchetti, Devis Benfaremo, Daniele Mauro, Francesco Ciccia & Fabio Massimo Perrotta. (2021) Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician. Expert Review of Clinical Immunology 17:11, pages 1199-1209.
Read now
Read now
Elia Valls Pascual, Lucía Martínez-Costa Pérez, Antonio Hernández Pons, José María López Ortega, Elena Grau García, Mara Albert Fort, Juan José Alegre Sancho & José Andrés Román Ivorra. (2021) The Role of Plasma Calprotectin in Non-infectious Uveitis. Current Eye Research 46:8, pages 1184-1192.
Read now
Read now
KY Kang, S-H Park & YS Hong. (2020) Relationship between faecal calprotectin and inflammation in peripheral joints and entheses in axial spondyloarthritis. Scandinavian Journal of Rheumatology 49:5, pages 397-404.
Read now
Read now
David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin & Pontus Karling. (2019) Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scandinavian Journal of Gastroenterology 54:2, pages 152-157.
Read now
Read now
RD Østgård, BW Deleuran, MY Dam, IT Hansen, AG Jurik & H Glerup. (2018) Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis. Scandinavian Journal of Rheumatology 47:1, pages 48-55.
Read now
Read now
Walter P. Maksymowych. (2017) An update on biomarker discovery and use in axial spondyloarthritis. Expert Review of Molecular Diagnostics 17:11, pages 965-974.
Read now
Read now
Daniel Wendling, Frank Verhoeven & Clément Prati. (2017) Calprotectin and spondyloarthritis. Expert Review of Clinical Immunology 13:4, pages 295-296.
Read now
Read now
Geir Larsson, Kotacherry Thrivikrama Shenoy, Ramalingom Ramasubramanian, Lakshmikanthan Thayumanavan, Leena Kondarappassery Balakumaran, Gunnar A. Bjune & Bjørn A. Moum. (2015) High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies. Infectious Diseases 47:3, pages 137-143.
Read now
Read now
A Kastbom, E Klingberg, D Verma, H Carlsten, H Forsblad-d’Elia, J Wesamaa, J Cedergren, P Eriksson & P Söderkvist. (2013) Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis. Scandinavian Journal of Rheumatology 42:6, pages 465-468.
Read now
Read now
Articles from other publishers (57)
Mehrnaz Nouri, Björn Weström & Shahram Lavasani. (2023) Elevated Fecal Calprotectin Accompanied by Intestinal Neutrophil Infiltration and Goblet Cell Hyperplasia in a Murine Model of Multiple Sclerosis. International Journal of Molecular Sciences 24:20, pages 15367.
Crossref
Crossref
Giacomo Cozzi, Laura Scagnellato, Mariagrazia Lorenzin, Edoardo Savarino, Fabiana Zingone, Francesca Ometto, Marta Favero, Andrea Doria, Stephan R. Vavricka & Roberta Ramonda. (2023) Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies. Nature Reviews Rheumatology 19:8, pages 503-518.
Crossref
Crossref
Lei Wang, Chuan Song, Yiwen Wang, Lidong Hu, Xingkang Liu, Jiaxin Zhang, Xiaojian Ji, Siliang Man, Nana Zhang, Gang Li, Yunsheng Yang, Lihua Peng, Zhimin Wei & Feng Huang. (2023) Symptoms compatible with Rome IV functional bowel disorder in patients with ankylosing spondylitis. Modern Rheumatology 33:4, pages 823-829.
Crossref
Crossref
Christina Heidt, Ulrike Kämmerer, Manfred Fobker, Andreas Rüffer, Thorsten Marquardt & Monika Reuss-Borst. (2023) Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis. Nutrients 15:10, pages 2386.
Crossref
Crossref
Kuan‐Kai Tung, Shih‐Tien Chen, Cheng‐Hung Lee, Chun‐Fang Tung & James Cheng‐Chung Wei. (2023) Calprotectin in spondyloarthritis and gut inflammation, is it clinically meaningful?. International Journal of Rheumatic Diseases 26:4, pages 609-612.
Crossref
Crossref
Júlia Faria Campos, Gustavo Gomes Resende & Maria de Lourdes Abreu Ferrari. (2022) Answer to “comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis”. International Journal of Rheumatic Diseases 26:1, pages 175-176.
Crossref
Crossref
Signe Holm Nielsen, Andrew Stahly, Emilie H. Regner, Anne-Christine Bay-Jensen, Morten A. Karsdal & Kristine A. Kuhn. (2022) Novel Biomarker of Collagen Degradation Can Identify Patients Affected With Both Axial Spondyloarthritis and Crohn Disease. The Journal of Rheumatology 49:12, pages 1335-1340.
Crossref
Crossref
Angela Saviano, Marcello Candelli, Christian Zanza, Andrea Piccioni, Alessio Migneco & Veronica Ojetti. (2022) Gastrointestinal Involvement in Extra-Digestive Disease: Which Is the Role of Fecal Calprotectin?. Medicina 58:10, pages 1384.
Crossref
Crossref
Jacqueline Chaparro-Olaya, Liliana Morales, Moisés David León Falla, Paula C. Hernández, Wilson Bautista-Molano, Alejandro Ramos-Casallas, Juliette de Ávila, Juan Manuel Bello-Gualtero, Fabián Cortés Muñoz & Consuelo Romero-Sánchez. (2022) Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp.. Scientific Reports 12:1.
Crossref
Crossref
Júlia Faria Campos, Gustavo Gomes Resende, Alfredo José Afonso Barbosa, Silas Castro de Carvalho, Junia Aguiar Lage, Pedro Ferrari Sales Cunha, Stela Cristina Silva de Souza & Maria de Lourdes Abreu Ferrari. (2022) Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis. International Journal of Rheumatic Diseases 25:9, pages 1078-1086.
Crossref
Crossref
Ariane Neumann. (2022) Rapid release of sepsis markers heparin-binding protein and calprotectin triggered by anaerobic cocci poses an underestimated threat. Anaerobe 75, pages 102584.
Crossref
Crossref
Letitia Toma, Mihai Dodot, Anca Zgura, Nicolae Bacalbasa, Andrei Silaghi, Razvan Simu, Teodora Isac & Adriana Mercan-Stanciu. (2021) Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus. Clinical and Experimental Medicine 22:2, pages 311-317.
Crossref
Crossref
Cem Ercalik, Mehmet Cetin Baskaya, Sebahat Ozdem & Bulent Butun. (2021) Investigation of asymptomatic intestinal inflammation in ankylosing spondylitis by fecal calprotectin. Arab Journal of Gastroenterology 22:4, pages 272-277.
Crossref
Crossref
Yu Zhang, Rulin Geng & Qiuyun Tu. (2021) Gut microbial involvement in Alzheimer's disease pathogenesis. Aging 13:9, pages 13359-13371.
Crossref
Crossref
Lovro Lamot, Marijana Miler, Rudolf Vukojević, Mandica Vidović, Mirta Lamot, Ivana Trutin, Nora Nikolac Gabaj & Miroslav Harjaček. (2021) The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients. Frontiers in Medicine 8.
Crossref
Crossref
Henrik Hovstadius, David Lundgren & Pontus Karling. (2021) Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study. Inflammatory Intestinal Diseases 6:2, pages 101-108.
Crossref
Crossref
Sônia Maria A. Anti Loduca Lima & Michel Alexandre Yazbek. (2020) Exames complementares das entesopatias. Parte 1 – Biomarcadores. Revista Paulista de Reumatologia:2020 out-dez;19(4), pages 60-64.
Crossref
Crossref
Marion Couderc, Bruno Pereira, Thierry Schaeverbeke, Thierry Thomas, Roland Chapurlat, Philippe Gaudin, Jacques Morel, Maxime Dougados & Martin Soubrier. (2020) GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis. BMJ Open 10:11, pages e038715.
Crossref
Crossref
Emily Garnett, Jayson Pagaduan, Deepthi Rajapakshe, Estella Tam, Richard Kellermayer & Sridevi Devaraj. (2020) Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population. Practical Laboratory Medicine 22, pages e00178.
Crossref
Crossref
Yubo Ma, Dazhi Fan, Shanshan Xu, Jixiang Deng, Xing Gao, Shiyang Guan & Faming Pan. (2020) Calprotectin in spondyloarthritis: A systematic review and meta-analysis. International Immunopharmacology 88, pages 106948.
Crossref
Crossref
Matthew A. Brown, Zhixiu Li & Kim-Anh Lê Cao. (2020) Biomarker development for axial spondyloarthritis. Nature Reviews Rheumatology 16:8, pages 448-463.
Crossref
Crossref
Xavier Romand, Chloé Bernardy, Minh Vu Chuong Nguyen, Anaïs Courtier, Candice Trocme, Margot Clapasson, Marie-Hélène Paclet, Bertrand Toussaint, Philippe Gaudin & Athan Baillet. (2020) La calprotectine dans les rhumatismes inflammatoires chroniques. Revue du Rhumatisme 87:4, pages 253-260.
Crossref
Crossref
Marine Fauny, Ferdinando D’Amico, Stefanos Bonovas, Patrick Netter, Silvio Danese, Damien Loeuille & Laurent Peyrin-Biroulet. (2020) Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review. Journal of Crohn's and Colitis 14:5, pages 688-693.
Crossref
Crossref
Sebastián Eduardo Ibáñez Vodnizza, María Paz Poblete De La Fuente & Elisa Catalina Parra Cancino. (2020) Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease. Rheumatic Disease Clinics of North America 46:2, pages 275-286.
Crossref
Crossref
Mariagrazia Lorenzin, Francesca Ometto, Augusta Ortolan, Mara Felicetti, Marta Favero, Andrea Doria & Roberta Ramonda. (2020) An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2093427.
Crossref
Crossref
Huji Xu & Jian Yin. (2019) HLA risk alleles and gut microbiome in ankylosing spondylitis and rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 33:6, pages 101499.
Crossref
Crossref
Xavier Romand, Chloé Bernardy, Minh Vu Chuong Nguyen, Anaïs Courtier, Candice Trocme, Margot Clapasson, Marie-Hélène Paclet, Bertrand Toussaint, Philippe Gaudin & Athan Baillet. (2019) Systemic calprotectin and chronic inflammatory rheumatic diseases. Joint Bone Spine 86:6, pages 691-698.
Crossref
Crossref
Elena L. Paley. (2019) Discovery of Gut Bacteria Specific to Alzheimer’s Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on Human Gut Metagenomics and Metabolomics. Journal of Alzheimer's Disease 72:1, pages 319-355.
Crossref
Crossref
Tor Olofsson, Elisabet Lindqvist, Elisabeth Mogard, Kristofer Andréasson, Jan Marsal, Mats Geijer, Lars Erik Kristensen & Johan K Wallman. (2019) Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort. Rheumatology 58:7, pages 1176-1187.
Crossref
Crossref
George E Fragoulis, Christina Liava, Dimitrios Daoussis, Euangelos Akriviadis, Alexandros Garyfallos & Theodoros Dimitroulas. (2019) Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World Journal of Gastroenterology 25:18, pages 2162-2176.
Crossref
Crossref
Mehmet Çağlayan, Pelin Oktayoğlu, Elif Ağaçayak, Abdullah Zübeyir Dagli, Mehmet Okçu & Kemal Nas. (2019) A New Comorbidity in Female Patients With Ankylosing Spondylitis. JCR: Journal of Clinical Rheumatology 25:1, pages 36-40.
Crossref
Crossref
Lucy Law, Jeanette Beckman Rehnman, Anna Deminger, Eva Klingberg, Lennart T. H. Jacobsson & Helena Forsblad-d’Elia. (2018) Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Fernanda Genre, Javier Rueda-Gotor, Sara Remuzgo-Martínez, Alfonso Corrales, Verónica Mijares, Rosa Expósito, Cristina Mata, Virginia Portilla, Ricardo Blanco, José Luis Hernández, Javier Llorca, Oreste Gualillo, Raquel López-Mejías & Miguel A. González-Gay. (2018) Association of circulating calprotectin with lipid profile in axial spondyloarthritis. Scientific Reports 8:1.
Crossref
Crossref
A. S. Avdeeva. (2018) CLINICAL SIGNIFICANCE OF CALPROTECTIN IN RHEUMATIC DISEASES. Rheumatology Science and Practice 56:4, pages 494-499.
Crossref
Crossref
Rene Y. Choi, Mark Asquith & James T. Rosenbaum. (2018) Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial?. Current Opinion in Rheumatology 30:4, pages 303-309.
Crossref
Crossref
Eva Klingberg, Hans Strid, Arne Ståhl, Anna Deminger, Hans Carlsten, Lena Öhman & Helena Forsblad-d’Elia. (2017) A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Silvia Speca & Laurent Dubuquoy. (2017) Chronic bowel inflammation and inflammatory joint disease: Pathophysiology. Joint Bone Spine 84:4, pages 417-420.
Crossref
Crossref
Francesca Ometto, Lara Friso, Davide Astorri, Costantino Botsios, Bernd Raffeiner, Leonardo Punzi & Andrea Doria. (2016) Calprotectin in rheumatic diseases. Experimental Biology and Medicine 242:8, pages 859-873.
Crossref
Crossref
Jinxian Huang, Zhihua Yin, Guoxiang Song, Shengjin Cui, Jinzhao Jiang & Lijun Zhang. (2017) Discriminating Value of Calprotectin in Disease Activity and Progression of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis. Disease Markers 2017, pages 1-5.
Crossref
Crossref
Andrea Levitova, Hana Hulejova, Maja Spiritovic, Karel Pavelka, Ladislav Senolt & Marketa Husakova. (2016) Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Ulf Lindström, Sofia Exarchou, Elisabeth Lie, Mats Dehlin, Helena Forsblad-d’Elia, Johan Askling & Lennart Jacobsson. (2016) Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Kristofer Andréasson, Bodil Ohlsson & Thomas Mandl. (2016) Elevated levels of faecal calprotectin in primary Sjögren’s syndrome is common and associated with concomitant organic gastrointestinal disease. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Latika Gupta, Shruti Bhattacharya, Vikas Agarwal & Amita Aggarwal. (2016) Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease. Clinical Rheumatology 35:12, pages 3075-3079.
Crossref
Crossref
Silvia Speca & Laurent Dubuquoy. (2016) Inflammation chronique de l’intestin et rhumatismes inflammatoires : physiopathologie. Revue du Rhumatisme Monographies 83:4, pages 197-202.
Crossref
Crossref
Mark J. Asquith, Patrick Stauffer, Sean Davin, Claire Mitchell, Phoebe Lin & James T. Rosenbaum. (2016) Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis. Arthritis & Rheumatology 68:9, pages 2151-2162.
Crossref
Crossref
H Cypers, G Varkas, S Beeckman, K Debusschere, T Vogl, J Roth, M B Drennan, M Lavric, D Foell, C A Cuvelier, M De Vos, J Delanghe, F Van den Bosch & D Elewaut. (2016) Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Annals of the Rheumatic Diseases 75:7, pages 1357-1362.
Crossref
Crossref
Klára Prajzlerová, Kristýna Grobelná, Karel Pavelka, Ladislav Šenolt & Mária Filková. (2016) An update on biomarkers in axial spondyloarthritis. Autoimmunity Reviews 15:6, pages 501-509.
Crossref
Crossref
E. Klingberg, G. Oleröd, O. Hammarsten & H. Forsblad-d’Elia. (2016) The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study. Osteoporosis International 27:6, pages 2027-2033.
Crossref
Crossref
Abhijeet Danve & James O'Dell. (2015) The ongoing quest for biomarkers in Ankylosing Spondylitis. International Journal of Rheumatic Diseases 18:8, pages 826-834.
Crossref
Crossref
Marlou P. M. Adriaanse, Linda J. T. M. van der Sande, Anita M. van den Neucker, Paul P. C. A. Menheere, Edward Dompeling, Wim A. Buurman & Anita C. E. Vreugdenhil. (2015) Evidence for a Cystic Fibrosis Enteropathy. PLOS ONE 10:10, pages e0138062.
Crossref
Crossref
Ane Krag Jakobsen, Lennart T. H. Jacobsson, Oliver Patschan, Johan Askling & Lars Erik Kristensen. (2014) Is Nephrolithiasis an Unrecognized Extra-Articular Manifestation in Ankylosing Spondylitis? A Prospective Population-Based Swedish National Cohort Study with Matched General Population Comparator Subjects. PLoS ONE 9:11, pages e113602.
Crossref
Crossref
Maureen C Turina, Joachim Sieper, Nataliya Yeremenko, Kristina Conrad, Hildrun Haibel, Martin Rudwaleit, Dominique Baeten & Denis Poddubnyy. (2014) Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis. Annals of the Rheumatic Diseases 73:9, pages 1746-1748.
Crossref
Crossref
Pelin OktayogluMehtap BozkurtNuriye MeteMehmet CaglayanSerda EmKemal Nas. (2023) Elevated Serum Levels of Calprotectin (Myeloid-Related Protein 8/14) in Patients with Ankylosing Spondylitis and Its Association with Disease Activity and Quality of Life. Journal of Investigative Medicine 62:6, pages 880-884.
Crossref
Crossref
Kristofer Andréasson, Tore Saxne, Agneta Scheja, Izabela Bartosik, Thomas Mandl & Roger Hesselstrand. (2014) Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren’s syndrome and rheumatoid arthritis. Arthritis Research & Therapy 16:1, pages R46.
Crossref
Crossref
C. Lahiff, P. Safaie, A. Awais, M. Akbari, L. Gashin, S. Sheth, A. Lembo, D. Leffler, A. C. Moss & A. S. Cheifetz. (2013) The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 37:8, pages 786-794.
Crossref
Crossref
Liesbet Van Praet, Peggy Jacques, Filip Van den Bosch & Dirk Elewaut. (2012) The transition of acute to chronic bowel inflammation in spondyloarthritis. Nature Reviews Rheumatology 8:5, pages 288-295.
Crossref
Crossref
Franziska G Matzkies, Stephan R Targan, Dror Berel, Carol J Landers, John D Reveille, Dermot PB McGovern & Michael H Weisman. (2012) Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study. Arthritis Research & Therapy 14:6, pages R261.
Crossref
Crossref